Advanced search
Publication Cover
Modern Rheumatology Volume 24, 2014 - Issue 1
Journal homepage
269
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study

Satoshi KuboThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Shunsuke FukuyoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Kunihiro YamaokaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Norifumi SawamukaiThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Masao NawataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Shigeru IwataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
,
Yasushi MizunoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, Japan
&
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Fukuoka 807-8555, JapanCorrespondence[email protected]
 show all
Pages 42-51 | Received 05 Nov 2012, Accepted 12 Feb 2013, Published online: 22 Nov 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kosaku Murakami, Masahiro Sekiguchi, Shintaro Hirata, Takao Fujii, Kiyoshi Matsui, Satoshi Morita, Koichiro Ohmura, Yutaka Kawahito, Norihiro Nishimoto, Tsuneyo Mimori & Hajime Sano. (2019) Predictive factors for structural remission using abatacept: Results from the ABROAD study. Modern Rheumatology 29:3, pages 406-412.
Read now
Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ryo Hiroshima, Hiromitsu Takaoka, Kosei Kawakami, Naoko Koenuma, Toshikatsu Shirahata & Shigeki Momohara. (2016) The efficacy of abatacept in Japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice. Modern Rheumatology 26:4, pages 499-506.
Read now

Articles from other publishers (8)

Satoshi Kubo, Yusuke Miyazaki, Yasuyuki Todoroki, Atsushi Nagayasu, Ryuichiro Kanda, Takafumi Aritomi, Satsuki Matsunaga, Masanobu Ueno, Ippei Miyagawa, Koshiro Sonomoto, Kentaro Hanami, Shingo Nakayamada & Yoshiya Tanaka. (2023) Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry. Rheumatology and Therapy 10:6, pages 1705-1723.
Crossref
Yoshiya Tanaka, Tsukasa Matsubara, Koichi Hashizume, Norihito Amano & Tsutomu Takeuchi. (2022) Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose: post hoc analysis of a randomized, placebo-controlled, phase 4 study . Modern Rheumatology 32:3, pages 500-507.
Crossref
Stinne Ravn Greisen & Bent Deleuran. (2021) Checkpoint Molecules in Rheumatology—or the Benefits of Being Exhausted. Current Rheumatology Reports 23:4.
Crossref
M. A. Borisova & G. V. Lukina. (2019) Analysis of the use of a selective modulator of cosmulation of T‑lymphocytes abatacept in the treatment of rheumatoid arthritis: data from international clinical practice. Medical alphabet 1:18, pages 13-23.
Crossref
Shinji Maeda, Satoshi Osaga, Tomoyo Maeda, Norihisa Takeda, Shin-ya Tamechika, Taio Naniwa & Akio Niimi. (2019) Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research. PLOS ONE 14:11, pages e0215192.
Crossref
Gabriela Angélica Martínez-Nava, Javier Fernández-Torres, Karina Martínez-Flores, Yessica Zamudio-Cuevas, Denise Clavijo-Cornejo, Rolando Espinosa-Morales, Carlos A. Lozada, Marwin Gutierrez, Julio Granados, Carlos Pineda, Vicente Madrid-Marina & Alberto López-Reyes. (2018) The association of AKNA gene polymorphisms with knee osteoarthritis suggests the relevance of this immune response regulator in the disease genetic susceptibility. Molecular Biology Reports 45:2, pages 151-161.
Crossref
Satoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, Shintaro Hirata, Shunsuke Fukuyo, Ippei Miyagawa, Kentaro Hanami, Kazuyoshi Saito & Yoshiya Tanaka. (2016) Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching. Annals of the Rheumatic Diseases 75:7, pages 1321-1327.
Crossref
Stinne Ravn Greisen, Karen Kræmmer Schelde, Tue Kruse Rasmussen, Tue Wenzel Kragstrup, Kristian Stengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, Peter Junker, Mikkel Østergaard, Bent Deleuran & Malene Hvid. (2014) CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic `window of opportunity'. Arthritis Research & Therapy 16:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.